openPR Logo
Press release

Asthma Drugs Market Grows with Biologic Therapies, Air Pollution Awareness & Personalized Treatment

07-14-2025 08:18 AM CET | Health & Medicine

Press release from: DataM intelligence 4 Market Research LLP

Asthma Drugs Market

Asthma Drugs Market

The Global Asthma Drugs Market reached US$ 25.72 billion in 2024 and is expected to reach US$ 37.62 billion by 2032, growing at a CAGR of 5.2% during the forecast period 2025-2032.

The latest Asthma Drugs Market Report by DataM Intelligence offers a clear analysis of global trends, market size, key players, and growth drivers. Covering emerging technologies, evolving care models, and regulatory insights, it provides strategic intelligence to help stakeholders navigate the dynamic healthcare landscape through 2025-2033

Download exclusive insights with our detailed sample report (Corporate Email ID gets priority access):
https://www.datamintelligence.com/download-sample/asthma-drugs-market?ophp

Asthma drugs are medications used to prevent or treat airway inflammation and bronchoconstriction, including corticosteroids, bronchodilators, and biologics. Market growth is fueled by rising asthma prevalence, environmental triggers, and development of personalized biologic therapies with fewer side effects.

Asthma Drugs Market Competitors Overview:

The major global players in the asthma drugs market include AstraZeneca, GSK plc, Teva Pharmaceutical Industries Ltd., Merck & Co., Inc., Regeneron Pharmaceuticals, Inc., Sanofi, Amgen Inc., Covis Pharma, and Camber Pharmaceuticals, Inc. among others.

Important Industry Updates of 2024 and 2025:

✅ In January 2024, AstraZeneca announced that AIRSUPRA (albuterol/budesonide) is now commercially available in the United States by prescription. This medication received FDA approval for the as-needed treatment or prevention of asthma symptoms and to help prevent sudden severe breathing problems, also known as asthma attacks, in individuals aged 18 years and older.

Asthma Drugs Market Segments Overview:

∎ By Drug Class (Inhaled Corticosteroids, Leukotriene Modifiers, Long-Acting Beta Agonists (LABAs), Quick-Relief Medications, Combination Inhalers,
Biologics, Others)
∎ By Route of Administration (Inhalation, Oral, Others)
∎ By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/asthma-drugs-market?ophp

Methodology and Scope:

This Asthma Drugs Market report is developed using a robust research methodology that combines primary interviews, insights from industry experts, and verified secondary sources such as company filings, trade journals, and trusted databases. It follows a bottom-up and top-down approach to ensure data accuracy through triangulation. The scope of the report covers current market trends, growth potential, and strategic developments across global and regional markets.

Regional Overview for Asthma Drugs Market:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Looking For Exclusive Full Report? Get it here: https://www.datamintelligence.com/buy-now-page?report=asthma-drugs-market?ophp

The Report Includes:

➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.
➡ Go-to-market Strategy.
➡ Neutral perspective on the market performance.
➡ Customized regional/country reports as per request and country level analysis.
➡ Potential & niche segments and regions exhibiting promising growth covered.

People Also Ask:

➤ What are the global sales, production, import, and export trends in the Asthma Drugs market?
➤ Who are the top manufacturers, and what are their output, pricing, and revenue figures?
➤ What key opportunities and challenges do vendors face in this market?
➤ Which product types, applications, or end-users are driving growth and holding market share?
➤ What are the main growth drivers and restraints affecting the Asthma Drugs market?

Unlock 360° Market Intelligence with DataM Subscription Services:
https://www.datamintelligence.com/reports-subscription

✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Pipeline Analysis For Drugs Discovery
✅ Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Competitive Landscape

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Asthma Drugs Market Grows with Biologic Therapies, Air Pollution Awareness & Personalized Treatment here

News-ID: 4102228 • Views:

More Releases from DataM intelligence 4 Market Research LLP

United States Agave Syrup Market 2025 | Growth Drivers, Key Players & Investment Opportunities
United States Agave Syrup Market 2025 | Growth Drivers, Key Players & Investment …
Market Size and Growth The Global Agave Syrup Market size USD 643.48 million in 2022 and is projected to witness lucrative growth by reaching up to USD 1,039.88 million by 2030. The market is growing at a CAGR of 6.3% during the forecast period (2024-2031). Key Development: ✅ In 2025, the U.S. market shows strong demand from plant-based diets and health-driven consumer behavior: usage in beverages up ~39%, in bakery ~32%, and confectionery
United States Vegan Cheese Market 2025 | Rising Demand, Innovation & Market Expansion Trends
United States Vegan Cheese Market 2025 | Rising Demand, Innovation & Market Expa …
Market Size and Growth Vegan Cheese Market is predicted to reach a CAGR of 15% during the forecast period (2024-2031). Key Development: United States: Recent Industry Developments ✅ In May 2025, Daiya introduced its first-to-market dairy-free cream cheese packets (1-oz) specifically for foodservice operators, aiming to meet demand for portable and convenient plant-based cream cheese options. ✅ In March 2025, New Culture secured over US$5 million in early demand from pizza chefs and restaurant operators
United States Vegan Eggs Market 2025 | Growth Drivers, Key Players & Investment Opportunities
United States Vegan Eggs Market 2025 | Growth Drivers, Key Players & Investment …
Market Size and Growth The Global Vegan Eggs Market reached US$ 1.5 billion in 2022 and is expected to reach US$ 4.5 billion by 2030 and grow with a CAGR of 14.8% during the forecast period 2024-2031. The consumption of meat and animal products decreased due to the fear of diseases. Key Development: United States: Recent Vegan Egg Developments ✅ In August 2025, UK startup Plant Heads launched its vegan liquid egg "Crackd"
United States Biologics Contract Manufacturing Market Accelerates with Growing Biopharma Outsourcing and Need for Scalable Production | Key Players: Wuxi Biologics, AGC Biologics, Lonza, FUJIFILM Diosynth Biotechnologies
United States Biologics Contract Manufacturing Market Accelerates with Growing B …
Outsourced biologics manufacturing including monoclonal antibodies (mAbs), vaccines, and advanced therapies such as cell and gene treatments has become essential to driving biopharma innovation. According to DataM Intelligence, the global biologics contract manufacturing market was valued at USD 26.03 billion in 2024 and is projected to reach USD 83.47 billion by 2033, expanding at a CAGR of 14.0% between 2025 and 2033. Download exclusive insights with our detailed sample report (Corporate

All 5 Releases


More Releases for Drug

Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights: * Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029 * Global and Regional Antibody Drug Conjugate Market Insight * Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023 * Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight * Insight On Antibody Drug Conjugates In Clinical Trials: > 550
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase